FindTrial
Sign In

Clinical Application Analysis of Polidocanol Combined with Electrocoagulation in the Treatment of Epistaxis Caused by Hereditary Telangiectasia

Clinical Application Analysis of Polidocanol Combined with Electrocoagulation in the Treatment of Epistaxis Caused by Hereditary Telangiectasia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113326
Enrollment
Unknown
Registered
2025-11-27
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary hemorrhagic telangiectasia

Interventions

Observation group:Traditional endoscopic electrocoagulation surgery
Experimental group:Treatment using endoscopic nasal electrocoagulation hemostasis combined with local injection of glyoxylate for hemostasis

Sponsors

Rugao People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with hereditary telangiectasia

Exclusion criteria

Exclusion criteria: 1. Those with abnormal coagulation function and liver/kidney function; 2. Those with bleeding caused by trauma, nasal cavity and sinus neoplasms, or blood system diseases, etc.

Design outcomes

Primary

MeasureTime frame
Frequency of bleeding;Amount of bleeding;—

Secondary

MeasureTime frame
Minimum hemoglobin level;—

Countries

China

Contacts

Public ContactMao Qingjie

Rugao People's Hospital

xuminxxn@163.com+86 136 4619 9803

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026